Evidence map›Paper›PMID 37882652›Full record

ReviewRNA biology2023

Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy.

Wei Wang, Lei Sun, Meng-Ting Huang, Yun Quan, Tao Jiang, Zhichao Miao, Qiong Zhang

Open access · goldAbstract readReview
In one paragraph

Review in RNA biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Dual-functional nanoplatform for simultaneous degradation of circRNAJournal of Zhejiang University. Science. B · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Nucleic acid therapeutics: Past, present, and future.Molecular therapy. Nucleic acids · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wei WangGuangzhou National Laboratory, Guangzhou, Guangdong, China.
Lei SunGuangzhou National Laboratory, Guangzhou, Guangdong, China.
Meng-Ting HuangGuangzhou National Laboratory, Guangzhou, Guangdong, China.
Yun QuanGuangzhou National Laboratory, Guangzhou, Guangdong, China.
Tao JiangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China.
Zhichao MiaoGuangzhou National Laboratory, Guangzhou, Guangdong, China.
Qiong ZhangGuangzhou National Laboratory, Guangzhou, Guangdong, China.ORCID 0000-0001-9790-3625
Guangzhou Experimental Station · CNAcademy of Military Medical Sciences · CNTongji University · CN

Funding

National Key R&D Program of China 2021YFF1200900, 2021YFF1200903Natural Science Foundation of China 32270707Program of Guangzhou Laboratory SRPG22-006R&D Program of Guangzhou Laboratory SRPG22-002R&D Program of Guangzhou Laboratory SRPG22-003R&D Program of Guangzhou Laboratory SRPG22-007R&D Program of Guangzhou Laboratory YW-JCYJ0612State Key Laboratory of Pathogen and Biosecurity SKLPBS2238Young Scientists Program of Guangzhou Laboratory NPG23-05
6 · The paper itself

Abstract

Circular RNA (circRNA) forms closed loops via back-splicing in precursor mRNA, resisting exonuclease degradation. In higher eukaryotes, protein-coding genes create circRNAs through exon back-splicing. Unlike mRNAs, circRNAs possess unique production and structural traits, bestowing distinct cellular functions and biomedical potential. In this review, we explore the pivotal roles of viral circRNAs and associated RNA in various biological processes. Analysing the interactions between viral circRNA and host cellular machinery yields fresh insights into antiviral immunity, catalysing the development of potential therapeutics. Furthermore, circRNAs serve as enduring biomarkers in viral diseases due to their stable translation within specific tissues. Additionally, a deeper understanding of translational circRNA could expedite the establishment of circRNA-based expression platforms, meeting the rising demand for broad-spectrum viral vaccines. We also highlight the applications of circular RNA in biomarker studies as well as circRNA-based therapeutics. Prospectively, we expect a technological revolution in combating viral infections using circRNA.

Indexed as

MicroRNAsVirus DiseasesHumansRNARNA, CircularRNA, MessengerRNA SplicingRNA, ViralMicroRNAsRNARNA, CircularRNA, MessengerRNA, Viralback-splicingCircular RNAsdiagnostic markerimmunogenicitynucleic acid vaccinetranslation

Identifiers

PMID37882652
PMCPMC10730172
OpenAlexW4387949590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.